Heqirui Medicine Appoints Dr. Henri Doods as Chief Executive Officer
Time of Update: 2021-09-20
Henri Nico Doods served as the senior vice president of Boehringer Ingelheim and the global head of Boehringer Ingelheim Research Beyond Border-RBB before joining Heqirui Medicine.
Co-founded by Dr. Wang Xiaodong!
Time of Update: 2021-09-19
The latest announcement by the Center for Drug Evaluation (CDE) of the State Drug Administration of China, Viterilon (Beijing) Biotechnology Co. , Ltd. (Sironax, hereinafter
Linlu Pharmaceutical Appoints Dr. Feng Luo as Chief Development Officer
Time of Update: 2021-08-27
In the position of Chief R&D Officer, in addition to leading the establishment of the preclinical and translational medicine department of Linglu, Dr.
Akzo Nobel Dr. Lin Liangqi won the "Magnolia Memorial Award"
Time of Update: 2021-08-17
Global Coatings Network News: The 2015 Shanghai "Magnolia Memorial Award" award ceremony was successfully concluded on September 8.
Dr. Wang Haining: Looking forward to conducting more research on thyroid diseases through the platform of the "Tyroid Special Committee"
Time of Update: 2021-08-09
Wang Haining, a member of the Thyroid Professional Committee of the Beijing Society of Endocrinology and Metabolism and the Department of Endocrinology, Peking University Third Hospital, for an interview .
How to extend life: Dr. Moseley talks about how to maintain a good balance can extend life
Time of Update: 2021-08-07
In order to maintain a good balance, our brain must be able to integrate a large amount of information from the whole body, Professor Skelton said .
Unswervingly continue to invest in local production and innovation-a meeting with Dr. Ke Diwen, President and Chairman of BASF Greater China
Time of Update: 2021-08-06
Last year, BASF established a biodegradable laboratory in Shanghai Innovation Park, the largest R&D hub in the Asia-Pacific region, to respond to the increasing demand for biodegradability and expanded the product portfolio of the global interdisciplinary R&D department .
Dr. Hongbo Chi Nature published an article: CRISPR-Cas9 technology analyzes the selective regulation of key immune cells
Time of Update: 2021-08-05
Jude Children’s Research Hospital in the United States has discovered a biological pathway that can selectively regulate the development of key immune cells: the development and humoral immune response called Tfh (follicular helper cells) .
Medicilon appoints Dr. Xuedong Dai as Executive Vice President of International R&D Services
Time of Update: 2021-08-02
Dai Xuedong as Executive Vice President of Medicilon International R&D Services .
The latest article by Dr. Wei Wei: The first analysis of fatty acid metabolism in cancer cells with single-cell resolution
Time of Update: 2021-07-28
Wei Wei, Assistant Professor of the ISB Institute, who led the research, said: “This work is the first example of analyzing fatty acid uptake and abnormal protein signals in cancer cells with single-cell resolution.
Dr. Zeng Zhengmao: Private investment "large-scale environmental protection industrialization" model profitable
Time of Update: 2021-07-25
, the landfill site can be leased to investors by the government. The investor sorts and recycles the waste that is excavated. For the two major types of combustible and non-combustible garbage, instead of traditional
Nuocheng Jianhua appoints Dr. Xiangyang Zhang as Chief Medical Officer
Time of Update: 2021-07-23
Xiangyang Zhang, who has extensive clinical and new drug development experience in the field of biomedicine, as the chief medical officer and co-founder of Nuocheng Jianhua , Chairman and CEO Dr.
Nuocheng Jianhua, Dr. Jisong Cui, was selected as one of the 15 people who influenced the innovation of China's biomedical industry
Time of Update: 2021-07-20
On March 9, 2021, DeepTech's media platform SciPhi, which focuses on the content and data of the entire chain of life science industrialization, paid close attention to the important
Chuangsheng Group announced the appointment of Dr. Xichen Zhang as Senior Vice President
Time of Update: 2021-07-14
Before joining Chuangsheng Group, he served as Amgen's product quality director, leading the quality work of multiple new drug development projects in different clinical development stages including Sensipar/Mimpara, Parsabiv, AMG223, AMG282, AMG420, AMG479, AMG592 and AMG510 .
Genting Shinyao appoints Dr. Wei Yang as Chief Scientific Officer
Time of Update: 2021-07-09
Yang said: “I am very happy to join Genting Shinyao, an excellent team of professionals in the global medical and health field, bringing innovative medicines to patients in urgent need of treatment in China and around the world .
Genxi Biotech appointed Dr. Yajin Ni, a senior expert in the field of gene and cell therapy, as the chief technology officer
Time of Update: 2021-07-06
and operation department, led the development of allogeneic CAR-T products, and successfully applied a number of models to the human body for the first time The allogeneic CAR-T candidate products of the company have advanced from the preclinical stage
The future of continuous flow technology education can be expected-an interview with Dr. Jiang Yi
Time of Update: 2021-06-28
At the meeting, domestic and foreign experts conducted discussions on the new international trends of continuous flow technology and the new developments in the application of talent education and scientific research in universities through online and offline methods .
Tumor vaccine has been designated by the FDA for fast-track entry for the treatment of recurrent gliomas, Dr. Mai Meng broke the news
Time of Update: 2021-06-22
will open in Shanghai /MedClub News/--Recently, VBI VACCINES announced that VBI-1901, which uses granulocyte macrophage colony stimulating factor (GM-CSF) as an adjuvant, has been granted Fast Track designation by the FDA for the treatment of first relapse
Dr. Ying Chen: Innovative cultivator of ecological health
Time of Update: 2021-06-22
teaches theoretical knowledge at a university to a manager of a central enterprise engaged in project management; from theoretical research to practical application of landscape design, tourism planning, and ecological landscape patterns, what she has
The truth behind ulcers and weakness, Dr. Xiangya will show you the truth
Time of Update: 2021-05-09
Came to the neurology clinic of our hospital, and re-examination of the head MRI showed that there are multiple abnormal signal lesions in the double frontal parietal lobe, lateral ventricle, corpus callosum pressure, and right basal ganglia: demyelinating disease?